Beale, Sophie; Bagust, Adrian; Shearer, Arran; Martin, Alan - In: PharmacoEconomics 24 (2006) 1, pp. 21-34
<Emphasis Type="Bold">Introduction: Recent clinical trial results have demonstrated that, in patients with type 2 diabetes, second-line treatment of rosiglitazone in combination with metformin can lead to significant improvements in the control of fasting plasma glucose/glycosylated haemoglobin A<Subscript>1c</Subscript> (HbA<Subscript>1c</Subscript>) after the...</subscript></subscript></emphasis>